Hexindai (NASDAQ:HX) and SBI (OTCMKTS:SBHGF) are both finance companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, earnings, dividends, institutional ownership, analyst recommendations, risk and profitability.
Insider & Institutional Ownership
4.3% of Hexindai shares are owned by institutional investors. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
This is a summary of current ratings and target prices for Hexindai and SBI, as reported by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Valuation and Earnings
This table compares Hexindai and SBI’s top-line revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Hexindai||$107.26 million||1.26||$65.48 million||N/A||N/A|
|SBI||$3.04 billion||1.68||$420.15 million||N/A||N/A|
SBI has higher revenue and earnings than Hexindai.
Hexindai pays an annual dividend of $0.25 per share and has a dividend yield of 9.4%. SBI does not pay a dividend.
Volatility & Risk
Hexindai has a beta of 1.36, indicating that its stock price is 36% more volatile than the S&P 500. Comparatively, SBI has a beta of 4.96, indicating that its stock price is 396% more volatile than the S&P 500.
This table compares Hexindai and SBI’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
Hexindai Inc. operates a consumer lending marketplace that facilitates loans in China. It primarily focuses on facilitating medium-sized credit loans. The company provides borrowers a range of products based on customer segmentation data and tailored to the specific needs of the emerging middle class; and investors various types of investment products. The company was founded in 2013 and is headquartered in Beijing, China.
SBI Holdings, Inc., together with its subsidiaries, engages in the online financial service businesses and investment activities in Japan and internationally. It operates through Financial Services Business, Asset Management Business, and Biotechnology-Related Business segments. The Financial Services Business segment provides various financial products and services, including brokerage and investment banking, banking, nonlife insurance and short-term small-amount insurance, and housing loan services; and credit card, leasing, remittance, peer-to-peer lending, and other services, as well as foreign-exchange market participant services. This segment operates proprietary trading system, which allows investors to trade stocks and bonds through electronic trading systems without stock exchanges. The Asset Management Business segment is involved in the venture capital, buyout investment, and financial and economic information activities. This segment also provides asset management services; and invests in hedge funds and private equity funds. The Biotechnology-Related Business segment develops, distributes, and sells pharmaceutical products, health foods, and cosmetics with 5-ALA as ingredient. This segment is also involved in the research and development of treatment methods and pharmaceuticals in autoimmune diseases and cancer fields. The company is also involved in the operation of various online intermediate services; development and trading of investment properties; provision of guarantee services for house rentals; and manufacture of mining chips, and development of mining systems. The company was formerly known as Softbank Investment Corporation and changed its name to SBI Holdings, Inc. in July 2005. SBI Holdings, Inc. was founded in 1999 and is headquartered in Tokyo, Japan.
Receive News & Ratings for Hexindai Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hexindai and related companies with MarketBeat.com's FREE daily email newsletter.